IP Verse

Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs - EP2345425

The patent EP2345425 was granted to Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Jul 11, 2018. The application was originally filed on Dec 26, 2006 under application number EP11162751A. The patent is currently recorded with a legal status of "Revoked".

EP2345425

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP11162751A
Filing Date
Dec 26, 2006
Status
Revoked
Jun 25, 2021
Grant Date
Jul 11, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

OCTAPHARMAApr 11, 2019ULLRICH & NAUMANN PARTG MBBADMISSIBLE
TAKEDA PHARMACEUTICALSApr 11, 2019HOFFMANN EITLEADMISSIBLE

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0703922
DESCRIPTIONEP1059088
DESCRIPTIONUS4764369
DESCRIPTIONWO0127623
DESCRIPTIONWO02092632
DESCRIPTIONWO2004091656
DESCRIPTIONWO9429334
DESCRIPTIONWO9964462
OPPOSITIONCA2136698
OPPOSITIONEP0122909
OPPOSITIONEP0246579
OPPOSITIONEP0276342
OPPOSITIONEP0330647
OPPOSITIONEP1059088
OPPOSITIONEP2345425
OPPOSITIONFR513311
OPPOSITIONUS2004101909
OPPOSITIONUS5164487
OPPOSITIONWO0127623
OPPOSITIONWO0158510
OPPOSITIONWO2004091656
OTHEREP1059088
SEARCHWO0127623
SEARCHWO0158510
SEARCHWO02092632

Non-Patent Literature (NPL) Citations (57) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BERNEMAN A. ET AL., EUR. J. IMMUNOL., (1992), vol. 22, pages 625 - 631-
DESCRIPTION- BLEEKER W.K. ET AL., BLOOD, (2000), vol. 95, pages 1856 - 1861-
DESCRIPTION- BOUVET J.P. ET AL., J. AUTOIMMUN., (2001), vol. 16, no. 2, pages 163 - 172-
DESCRIPTION- BOUVET J.-P. ET AL., JOURNAL OF AUTOIMMUNITY, (2001), vol. 16, pages 163 - 172-
DESCRIPTION- BUCHTA C. ET AL., BIOLOGICALS, (2005), vol. 33, pages 41 - 48-
DESCRIPTION- COHN ET AL., J. AM. CHEM. SOC., (1946), vol. 68, page 459-
DESCRIPTION- COPELAN E.A ET AL., TRANSFUSION, (1986), vol. 26, pages 410 - 412-
DESCRIPTION- GOUTINHO A. ET AL., CURR. OPIN. IMMUNOL., (1995), vol. 7, pages 812 - 818-
DESCRIPTION- HOUT M.S ET AL., ASAIO J, (2000), vol. 46, no. 6, pages 702 - 706-
DESCRIPTION- KAZATCHKINE M.D. ET AL., IMMUNOL. REV., (1994), vol. 139, pages 79 - 107-
DESCRIPTION- LACROIX-DESMAZES ET AL., J. IMMUNOL. METHODS, (1988), vol. 216, pages 117 - 137-
DESCRIPTION- MAZID M.A ET AL., J.APPL.BIOMATER., (1992), vol. 3, no. 1, pages 9 - 15-
DESCRIPTION- MISBAH S.A ET AL., DRUG SAFETY, (1993), vol. 9, pages 254 - 262-
DESCRIPTION- ONCLEY ET AL., J. AM. CHEM. SOC., (1949), vol. 71, page 541-
DESCRIPTION- STEINBUCH ET AL., REV. FRANç. ET. CLIN. ET BIOL., (1969), vol. XIV, page 1054-
DESCRIPTION- TEELING J.L ET AL., BLOOD, (20010815), vol. 98, no. 4, pages 1095 - 1099-
DESCRIPTION- WILSON J,R. ET AL., MUSCLE & NERVE, (1997), vol. 29, no. 9, pages 1142 - 1145-
OPPOSITION- "Antibody Therapies IVEEGAM EN IGIV", Baxter.com, (20040000), XP055584976-
OPPOSITION- BERNEMAN et al., "Natural mouse IgG reacts with self antigens including molecules involved in the immune response", Eur. J. Immunol., (19920000), vol. 22, pages 625 - 633, XP055474932-
OPPOSITION- BLOMBERG et al., "Improved Removal of Anti-A and Anti-B Antibodies from Plasma Using Blood-Group-Active Haptens", Vox Sang, (19930000), vol. 95, pages 126 - 135, XP002941315-
OPPOSITION- "Business Update; Biotest increases its market share worldwide, announces ambitious targets for 2006", Science Letter, (20060428), XP055584959-
OPPOSITION- European Pharmacopoeia, (20040000), vol. 1, pages 1742 - 1746-
OPPOSITION- Experimental results Subcuvia antiA_antiB VNG1S020-
OPPOSITION- Experimentl results anti AB Lessines-
OPPOSITION- HAS Opinion ''Tegeline®-
OPPOSITION- L. BIESERT, "Vlrus validation studies of in:pJ\unoglbulin preparations", Clinical and Experimental Rheumatology, (19960000), vol. 14, no. 15, pages S47 - S52, XP055584987-
OPPOSITION- M. M. EIBL et al., "lgG subclass distribution in intravenous immunoglobulin preparations", Journal of Infection, (19880000), vol. 17, pages 271 - 276, XP055584999-
OPPOSITION- "Octagam 5%", medicines.org, (20170626), XP055584966-
OPPOSITION- OHIM, ENDOBULIN, Registration Certificate, (19990000), Database accession no. 000138743-
OPPOSITION- OHIM, SUBCUVIA, Registration Certificate, (20020000), Database accession no. 002360246-
OPPOSITION- P. A. RAMSLAND et al., "Evidence for structurally conserved recognition of the major carbohydrate xenoantigen by natural antibodies.", Cellular and Molecular Biology, (20030000), vol. 49, no. 2, pages 307 - 317, XP055584953-
OPPOSITION- Product Approval Information of ''Octagam®-
OPPOSITION- Quality control Endobulin (including anti AB-
OPPOSITION- R. LEMIEUX et al., "Therapeutic intravenous immunoglobulins", Molecular Immunology, (20050000), vol. 42, pages 839 - 848, XP027634945-
OPPOSITION- BOUVET et al., "Induction of Natural Autoantibody Activity Following Treatment of Human Immunoglobulin with Dissociating Agents", J. of Autoimmunol., (20010000), vol. 16, pages 163 - 172, XP055582897
OPPOSITION- RYDBERG et al., "In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose", Transpl. Int., (20050000), vol. 17, no. 11, pages 666 - 672, XP019323995
OPPOSITION- BUCHTA et al., "Potential approaches to prevent uncommon hemolytic side effects of ABO antibodies in plasma derivatives", Biologicals, (20050000), vol. 33, pages 41 - 48, XP004745182
OPPOSITION- C. BUCHTA et al., "Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives", Biologicals, (20050000), vol. 33, pages 41 - 48, XP004745182
OPPOSITION- THORPE et al., "Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method", Biologicals, (20050000), vol. 33, pages 111 - 116, XP004918421
OPPOSITION- LACROIX-DESMAZE et al., "Self-reactive antibodies ( natural autoantibodies) in healthy individuals", J. of Immunol. Methods, (19980000), vol. 216, pages 117 - 137, XP027491596
OPPOSITION- J. L. LUNDBLAD et al., "Characterisation of various intravenous immunoglobulin preparations", Journal of Infection, (19870000), vol. 15, no. 1, pages 3 - 12, XP055584991
OPPOSITION- KNEZEVIC-MARAMICA et al., "Intravenous immune globulins: an update for clinicians", Transfusion, (20030000), vol. 43, pages 1460 - 1480, XP002400780
OPPOSITION- LAMOUREUX et al., "Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?", Intern. Immunol., 2004, (20040000), vol. 16, no. 7, pages 929 - 936, XP055582922
OPPOSITION- BRULEY-ROSSET et al., "Polyreactive Autoantibodies Purified from Human Intravenous Immunoglobulins Prevent the Development of Experimental Autoimmune Diseases", Laboratory Investigation, (20030000), vol. 83, no. 7, pages 1013 - 1023, XP002535282
OPPOSITION- M. BRULEY-ROSSET et al., "Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseases", Laboratory Investigation, (20030000), vol. 83, no. 7, pages 1013 - 1023, XP002535282
OTHER- BERNEMAN A. et al., "Natural mouse IgG reacts with self antigens including molecules involved in the immune response", Eur. J. Immunol., (19920300), vol. 22, no. 3, pages 625 - 631, XP055474932-
OTHER- LACROIX-DESMAZES et al., "Self-reactive antibodies (natural autoantibodies) in healthy individuals", J. Immunol. Methods, (19880700), vol. 216, no. 1-2, pages 117 - 137, XP004143131
SEARCH- CHAUDHARY RAJENDRA ET AL, "Application of flow cytometry in detection of red-cell-bound IgG in Coombs-negative AIHA.", HEMATOLOGY (AMSTERDAM, NETHERLANDS) AUG 2006, (200608), vol. 11, no. 4, ISSN 1607-8454, pages 295 - 300, XP008079950 [XP] 14,15 * the whole document *-
SEARCH- MISBAH SIRAJ A ET AL, "Adverse effects of intravenous immunoglobulin", DRUG SAFETY, (1993), vol. 9, no. 4, ISSN 0114-5916, pages 254 - 262, XP008069247 [X] 1-5,12,13 * page 258, column L, paragraph 1 *-
SEARCH- NICHOLLS M D ET AL, "HEMOLYSIS INDUCED BY INTRAVENOUSLY-ADMINISTERED IMMUNOGLOBULIN", MEDICAL JOURNAL OF AUSTRALIA, (1989), vol. 150, no. 7, ISSN 0025-729X, pages 404 - 406, XP008069268 [X] 1-5,12,13 * page 405, column R, line 2 *-
SEARCH- WANG Z ET AL, "Detection of red blood cell-bound immunoglobulin G by flow cytometry and its application in the diagnosis of autoimmune hemolytic anemia.", INTERNATIONAL JOURNAL OF HEMATOLOGY FEB 2001, (200102), vol. 73, no. 2, ISSN 0925-5710, pages 188 - 193, XP008079990 [X] 14,15 * the whole document *-
SEARCH- MAZID M A ET AL, "An improved affinity support and immunoadsorbent with a synthetic blood group oligosaccharide and polymer coating for hemoperfusion.", JOURNAL OF APPLIED BIOMATERIALS : AN OFFICIAL JOURNAL OF THE SOCIETY FOR BIOMATERIALS. SPRING 1992, (199204), vol. 3, no. 1, ISSN 1045-4861, pages 9 - 15, XP008069266 [AD] 1-15 * abstract *
SEARCH- BUCHTA CHRISTOPH ET AL, "Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives", BIOLOGICALS, (200503), vol. 33, no. 1, ISSN 1045-1056, pages 41 - 48, XP004745182 [XD] 1-5,12,13 * the whole document *
SEARCH- GORDON J M ET AL, "Levels of anti-A and anti-B in commercial immune globulins.", TRANSFUSION. 1980 JAN-FEB, (198001), vol. 20, no. 1, ISSN 0041-1132, pages 90 - 92, XP008069246 [A] 1-15 * the whole document *
SEARCH- COPELAN E A ET AL, "Hemolysis following intravenous immune globulin therapy.", TRANSFUSION. 1986 SEP-OCT, (198609), vol. 26, no. 5, ISSN 0041-1132, pages 410 - 412, XP008069245 [A] 1-15 * the whole document *
SEARCH- KNEZEVIC-MARAMICA IRINA ET AL, "Intravenous immune globulins: an update for clinicians.", TRANSFUSION. OCT 2003, (200310), vol. 43, no. 10, ISSN 0041-1132, pages 1460 - 1480, XP002400780 [X] 1-5,12,13 * page 1471, column R, paragraph 3 *
SEARCH- SHNAIDER A ET AL, "Severe Coombs'-negative autoimmune hemolytic anemia in a kidney transplant patient.", AMERICAN JOURNAL OF NEPHROLOGY 2001 NOV-DEC, (200111), vol. 21, no. 6, ISSN 0250-8095, pages 494 - 497, XP008079872 [X] 14,15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents